GlassScriptPhysician profile
Melba F Lewis
NPI 1831120021
$4,627.71
in general payments reported to CMS, 2019-2025
16 companies · $775 in 2025
The $775 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $66.66 · 2021: $360 · 2022: $2,179 · 2023: $680 · 2024: $355 · 2025: $775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,710 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,710.31 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,693.33 | 2022 | |
| Genzyme Corporation | $1,024.39 | 2020-2025 | |
| Acclarent, INC | $491.17 | 2019-2023 | Acclarent Aera, Trudi Nav Cable |
| Aerin Medical INC. | $457.24 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $250.42 | 2020-2025 | Dupixent |
| Arrinex, INC. | $146.55 | 2019 | |
| Sanofi-Aventis U.S. LLC | $98.99 | 2024 | |
| Glaxosmithkline, LLC. | $97.97 | 2021-2024 | Nucala |
| Xoran Technologies LLC | $97.67 | 2023 | Minicat |
| Optinose US, INC. | $59.15 | 2019-2024 | |
| Stryker Corporation | $53.65 | 2022 | |
| Lilly USA, LLC | $42.52 | 2025 | Mounjaro, Zepbound |
| Smith+Nephew, INC. | $31.77 | 2019-2022 | |
| Resmed Corp | $30.76 | 2023 | |
| Integra Lifesciences Corporation | $30.45 | 2025 | Acclarent Aera |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $21.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melba Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.